定量超声射频数据分析评估NAFLD肝脂肪变:以MRI-PDFF为参考标准
单中心前瞻性研究纳入120例临床疑诊NAFLD患者,比较基于射频数据的定量超声参数AC-TAI和SC-TSI与MRI-PDFF的相关性及诊断效能。AC-TAI与SC-TSI均与MRI-PDFF显著相关(r=0.659和0.727),SC-TSI诊断≥5%和≥10%肝脂肪含量的AUC分别为0.964和0.935。
要点
- SC-TSI诊断≥5%肝脂肪含量的AUC为0.964,诊断≥10%的AUC为0.935
- AC-TAI诊断≥5%肝脂肪含量的AUC为0.861,诊断≥10%的AUC为0.835
- SC-TSI与MRI-PDFF相关性(r=0.727)高于AC-TAI(r=0.659)
核心结论
- 定量超声射频数据分析所得的AC-TAI和SC-TSI与MRI-PDFF相关性良好,对NAFLD肝脂肪变的检出和严重程度评估有良好效能。
研究设计与样本
- 单中心前瞻性研究,2019年3月至2020年1月纳入120例临床疑诊NAFLD患者,均行超声射频数据采集和化学位移编码肝脏MRI-PDFF测量,以MRI-PDFF为参考标准。
关键影像表现/征象
- 基于组织衰减成像的衰减系数(AC-TAI)与MRI-PDFF的Pearson相关系数为0.659(p<0.001)。
- 基于组织散射分布成像的散射分布系数(SC-TSI)与MRI-PDFF的Pearson相关系数为0.727(p<0.001)。
- 按MRI-PDFF分组:<5%组38例,5-10%组23例,≥10%组59例。
诊断标准与关键数值
- AC-TAI诊断MRI-PDFF≥5%的AUC为0.861(95%CI: 0.786-0.918),诊断MRI-PDFF≥10%的AUC为0.835(95%CI: 0.757-0.897)。
- SC-TSI诊断MRI-PDFF≥5%的AUC为0.964(95%CI: 0.913-0.989),诊断MRI-PDFF≥10%的AUC为0.935(95%CI: 0.875-0.972)。
临床应用与阅片要点
- 定量超声射频参数AC-TAI和SC-TSI可用于NAFLD肝脂肪变的无创评估,SC-TSI诊断效能优于AC-TAI。
- 多因素线性回归显示MRI-PDFF是AC-TAI和SC-TSI的独立决定因素。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the diagnostic performance of quantitative ultrasound (US) parameters for the assessment of hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD) using magnetic resonance imaging proton density fat fraction (MRI-PDFF) as the reference standard.
MATERIALS AND METHODS: In this single-center prospective study, 120 patients with clinically suspected NAFLD were enrolled between March 2019 and January 2020. The participants underwent US examination for radiofrequency (RF) data acquisition and chemical shift-encoded liver MRI for PDFF measurement. Using the RF data analysis, the attenuation coefficient (AC) based on tissue attenuation imaging (TAI) (AC-TAI) and scatter-distribution coefficient (SC) based on tissue scatter-distribution imaging (TSI) (SC-TSI) were measured. The correlations between the quantitative US parameters (AC and SC) and MRI-PDFF were evaluated using Pearson correlation coefficients. The diagnostic performance of AC-TAI and SC-TSI for detecting hepatic fat contents of ≥ 5% (MRI-PDFF ≥ 5%) and ≥ 10% (MRI-PDFF ≥ 10%) were assessed using receiver operating characteristic (ROC) analysis. The significant clinical or imaging factors associated with AC and SC were analyzed using linear regression analysis.
RESULTS: The participants were classified based on MRI-PDFF: < 5% (n = 38), 5-10% (n = 23), and ≥ 10% (n = 59). AC-TAI and SC-TSI were significantly correlated with MRI-PDFF (r = 0.659 and 0.727, p < 0.001 for both). For detecting hepatic fat contents of ≥ 5% and ≥ 10%, the areas under the ROC curves of AC-TAI were 0.861 (95% confidence interval [CI]: 0.786-0.918) and 0.835 (95% CI: 0.757-0.897), and those of SC-TSI were 0.964 (95% CI: 0.913-0.989) and 0.935 (95% CI: 0.875-0.972), respectively. Multivariable linear regression analysis showed that MRI-PDFF was an independent determinant of AC-TAI and SC-TSI.
CONCLUSION: AC-TAI and SC-TSI derived from quantitative US RF data analysis yielded a good correlation with MRI-PDFF and provided good performance for detecting hepatic steatosis and assessing its severity in NAFLD.
引用
- Jeon SK, Lee JM, Joo I, et al. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. Korean J Radiol. 2021. PMID: 33739636. doi:10.3348/kjr.2020.1262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。